[1] Okamoto T. Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer[J]. World J Gastroenterol,2022,28(10):985-1008. [2] He X, Zhu Y, Wang Y, et al. Advances in stent therapy for malignant biliary obstruction[J]. Abdom Radiol (NY),2021,46(1):351-361. [3] Dutta A K, Basavaraju U, Sales L, et al. Radiofrequency ablation for management of malignant biliary obstruction: a single-center experience and review of the literature[J]. Expert Rev Gastroenterol Hepatol,2017,11(8):779-784. [4] Irisawa A, Katanuma A, Itoi T. Otaru consensus on biliary stenting for unresectable distal malignant biliary obstruction[J]. Dig Endosc,2013,25 Suppl 2:52-7. [5] Zheng X, Bo Z Y, Wan W, et al. Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction: a systematic review and meta-analysis[J]. J Dig Dis,2016,17(11):716-724. [6] 吴晓冬,刘松,王峰,等. 经T管超声胆管造影评估肝移植术后早期肝内外胆管[J]. 中国医学影像技术,2022,38(8):1203-1207. [7] 马天翼,万超,白成. 胆道支架治疗远端恶性胆道梗阻相关并发症的防治[J]. 中华消化内镜杂志,2023,40(3):248-252. [8] 范晨,孙飞虎,周琦,等. 高位恶性胆道梗阻行内支架成形术与胆肠吻合术疗效比较[J]. 中国医学计算机成像杂志,2022,28(1):78-81. [9] Tamura T, Kitano M. Role of CH-EUS as guidance for EUS-biliary drainage malignant obstruction[J]. Minerva Gastroenterol (Torino),2022,68(2):210-215. [10] Shaib Y, Rahal M A, Rammal M O, et al. Preoperative biliary drainage for malignant biliary obstruction: results from a national database[J]. J Hepatobiliary Pancreat Sci,2017,24(11):637-642. [11] Isayama H, Nakai Y, Kawakubo K, et al. Covered metallic stenting for malignant distal biliary obstruction: clinical results according to stent type[J]. J Hepatobiliary Pancreat Sci,2011,18(5):673-677. [12] 颜波,吕朋华,王福安,等. 胆道支架置入术联合125I条以及肝动脉化疗栓塞术治疗恶性胆道梗阻[J]. 介入放射学杂志,2022,31(11):1085-1088. [13] 杨毅,韩鸿宇,陈欢,等. 磁共振胰胆管成像与弥散加权成像联合CT增强扫描对恶性胆道梗阻的诊断价值[J]. 分子影像学杂志,2022,45(6):833-837. [14] 孙琦超,褚佳琦,徐培文,等. 磁共振胰胆管成像技术联合血清CA19-9水平在恶性胆道梗阻中的诊断价值[J]. 中国实验诊断学,2022,26(11):1689-1691. [15] 王宏博,杨业发,葛乃建. 肝外胆管癌的介入治疗现状与展望[J]. 中国癌症杂志,2022,32(2):118-124. [16] 洪颋樑,胡平方. 内镜超声引导下组织获取和引流治疗现状[J]. 中华消化杂志,2021,41(7):436-445. [17] 许保,陈正义,林松挺,等. ERCP或ERCP联合PTCD胆总管支架置入胆管引流治疗恶性梗阻性黄疸的临床价值[J]. 中国老年学杂志,2020,40(15):3218-3221. [18] 王陇利,聂芳,王彦清,等. 双通道超声造影在肝门部胆管癌分型及胆道低位梗阻病因诊断中的应用[J]. 中华医学杂志,2021,101(17):1262-1268. [19] 张亚平,周薇,张洪社,等. 磁共振胰胆管造影联合弥散加权成像在恶性胆道梗阻中的诊断价值研究[J]. 中国医药导报,2022,19(31):151-153,158. [20] Yazgan Y, Oncu K, Kaplan M, et al. Malignant biliary obstruction significantly increases serum lipid levels: a novel biochemical tumor marker?[J]. Hepatogastroenterology,2012,59(119):2079-2082. [21] 陶洁,黄波,邓勋伟,等. MRCP技术联合血清CEA、CA19-9及CA242检测在胆道恶性梗阻中的诊断价值[J]. 解放军医药杂志,2021,33(12):79-82,87. |